Abbott Laboratories (ABT) AI Analysis

ABT$108.52+1.27 +1.18%
Medical - DevicesLarge Cap
Compare
Market cap$187.95BEnterprise value$226.98BRevenue (TTM)$48.23BMarket positionTop 25%

Score

45
Neutral
Value
44
Quality
52
Growth
39

AI Score 75. Abbott Laboratories has a solid market capitalization of approximately $199.9 billion and a stable beta of 0.54, indicating lower volatility. However, its high price-to-earnings ratio of 42.8 and a negative price-to-earnings growth ratio suggest that the stock may be overvalued relative to its earnings growth potential

Abbott Laboratories (ABT) AI Analysis

ABT price $108.52 +1.27 +1.18%

Ticker
ABT
Price
$108.52
Change
+1.27 +1.18%
Market cap
$187.95B
P/E
39.98
Forward P/E
18.60
Dividend yield
2.18%
Beta
0.54
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
45
Value
44
Quality
52
Growth
39

Stocklytics score rationale: value 44, quality 52, growth 39.

AI Score 75. Abbott Laboratories has a solid market capitalization of approximately $199.9 billion and a stable beta of 0.54, indicating lower volatility. However, its high price-to-earnings ratio of 42.8 and a negative price-to-earnings growth ratio suggest that the stock may be overvalued relative to its earnings growth potential

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener